Last reviewed · How we verify
NCT05956249
Online Cognitive Behavioral Groupherapy for Mothers of Babies With Congenital Heart Disease
NA trial testing Online group therapy in Depressive Symptoms in 72 participants. Completed in 18 February 2025.
17 February 2025
Quick facts
| Lead sponsor | Instituto de Cardiologia do Rio Grande do Sul |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 10 June 2023 |
| Primary completion | 17 February 2025 |
| Estimated completion | 18 February 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Online group therapy
- Control Group — full drug profile →
Conditions studied
- Depressive Symptoms — all drugs for Depressive Symptoms →
- Anxiety State — all drugs for Anxiety State →
- Psychological Well-Being — all drugs for Psychological Well-Being →
Sponsor
Instituto de Cardiologia do Rio Grande do Sul — full company profile →
Who can join
Adults 18 to 45, female only, with Depressive Symptoms or Anxiety State. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Mothers of babies with congenital heart disease tend to have higher levels of depression, stress and anxiety. Currently, psychological support group technology has been a resource increasingly used by health professionals, with a therapeutic objective as an instrument to promote care. Objective: The aim of this study is to evaluate the effectiveness of a group intervention in improving depression, anxiety and the psychological well-being of mothers of babies with congenital heart disease. Methods: Randomized, parallel clinical trial, in which the factor under study will be online group therapy and the outcome the level of depressive symptoms, anxiety and psychological well-being, assessed using the instruments: BECK-II, BAI and Wellness Scale Ryff's psychological well-being at the beginning and after the intervention. The fellow who will reapply the instruments will be blinded to the groups. Patients will be randomized 1:1, with odd numbers assigned to treatment (online group therapy) and even numbers assigned to controls (no online group therapy). The intervention group will have 8 weekly group consultations, psychoeducational and focused on depression, anxiety and psychological well-being. The sample size was calculated at 36 individuals for each group. Data will be analyzed using the statistical program Statistical Package for Social Sciences (SPSS) version 27.0. For comparison between groups, Student's t test or Kruskall-Wallis or Chi-square test will be used. A two-tailed value of p≤ 0.05 will be considered significant. The normality of instrument scores will be evaluated using the Kolmogorov-Smirnov test. Covariance analysis will be performed to assess the influence of initial scores of anxiety, depression and well-being and their changes after intervention. The effect size will also be calculated. Expected results: It is expected to know and describe the population studied with regard to the level of depressive symptoms, anxiety and psychological well-being. In addition to seeking knowledge about the effectiveness of Group Therapy for these variables.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05956249
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depressive Symptoms
Currently open trials in the same condition.
- NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression · NA · recruiting
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
- NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
- NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting
Other Instituto de Cardiologia do Rio Grande do Sul trials
Trials by the same sponsor.
- NCT06917729 — Breathing Exercises of CardioBreath Application on Autonomic and Vascular Function in Hypertension · NA · not yet recruiting
- NCT06497946 — Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women · NA · recruiting
- NCT06282302 — Effect of Isometric and Aerobic Physical Exercise on Blood Pressure Levels in Hypertensive Elderly People · NA · unknown
- NCT06139653 — CardioBreathApp vs IMT in Heart Failure · NA · completed
- NCT03672760 — Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05956249 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Cardiologia do Rio Grande do Sul
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05956249.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing